Uptrend on the daily chart: above its 50- and 200-day averages · 50-day above the 200-day · SuperTrend up since Sep 22 · above the Ichimoku cloud · RSI 67 · MACD above its signal · at its 52-week high
None of the 29 investors followed here reported a position in DPLM.L in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a DPLM.L trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 22, 2026 | Bickerstaffe (Katie) | Bought at price 101.87 per share. | 246 | $25.06K |
| Sep 20, 2026 | Phyfer (Cheri Marie) | Bought at price 100.68 per share. | 1.2K | $124.94K |
| Sep 15, 2026 | Fidelity Investment Services Ltd | — | 3.20M | — |
| Sep 10, 2026 | Capital Group Companies, Inc. | — | 450.7K | — |
| Jul 16, 2026 | Gradden (Mandy) | Bought at price 96.63 per share. | 1K | $96.63K |
| Jul 15, 2026 | Bickerstaffe (Katie) | Bought at price 94.98 per share. | 133 | $12.63K |
| Jul 15, 2026 | Bickerstaffe (Katie) | Bought at price 95.01 per share. | 47 | $4.46K |
| Jul 15, 2026 | Ng (Wilson) | Bought at price 95.22 per share. | 424 | $40.37K |
| May 19, 2026 | Bickerstaffe (Katie) | Bought at price 90.39 per share. | 177 | $16.00K |
| Apr 15, 2026 | Norges Bank | — | 84.1K | — |
| Apr 6, 2026 | Capital Group Companies, Inc. | — | 1.53M | — |
| Mar 19, 2026 | Blackrock Advisors (Uk) Limited | — | 29.6K | — |
| Mar 19, 2026 | El-Mokadem (Ian) | Bought at price 77.63 per share. | 500 | $38.82K |
| Mar 18, 2026 | Bickerstaffe (Katie) | Bought at price 79.57 per share. | 251 | $19.97K |
| Mar 18, 2026 | Huse (Geraldine) | Bought at price 78.35 per share. | 535 | $41.92K |
| Jan 22, 2026 | Capital Group Companies, Inc. | — | 75.8K | — |
| Jan 15, 2026 | Thomson (Jonathan David) | Sold at price 75.84 per share. | 30K | $2.28M |
| Jan 13, 2026 | Bickerstaffe (Katie) | Bought at price 75.86 per share. | 352 | $26.70K |
| Jan 13, 2026 | El-Mokadem (Ian) | Bought at price 75.45 per share. | 500 | $37.73K |
| Dec 18, 2025 | Ng (Wilson) | Bought at price 71.81 per share. | 410 | $29.44K |
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 0.5 | 6.7 | 5.1 | 16.3 | 0.7 | 2.0 | 2.7 | 0.1 | 5.4 | 2.9 | +50.1% | ||
| 2025 | 7.1 | -1.2 | -14.5 | 3.0 | 18.3 | 4.3 | 10.1 | 0.4 | -1.8 | 5.7 | -2.6 | -3.1 | +24.6% |
| 2024 | -9.0 | 6.0 | 7.7 | -2.5 | 12.8 | 1.4 | 7.2 | 0.4 | -0.7 | -4.0 | 4.7 | -4.7 | +18.6% |
| 2023 | -1.7 | 1.9 | 1.0 | -4.4 | 12.9 | -1.6 | 8.5 | -3.2 | -4.1 | -5.4 | 17.9 | 6.9 | +29.0% |
| 2022 | -18.4 | -2.8 | -1.5 | 4.7 | -5.7 | -14.3 | 23.3 | -8.6 | -7.5 | 7.0 | 12.6 | -0.9 | −17.7% |
| 2021 | 5.7 | 0.0 | 9.9 | 12.6 | 0.6 | 0.6 | 1.9 | 3.7 | -7.3 | 5.7 | 6.7 | 5.2 | +53.9% |
| 2020 | -3.8 | -3.5 | -14.1 | 6.9 | 6.1 | -1.9 | 1.1 | 6.4 | 14.1 | 1.1 | -4.8 | 3.4 | +8.3% |
| 2019 | 5.0 | 6.5 | 7.8 | 9.7 | -7.1 | 3.1 | -1.0 | 4.5 | 4.9 | -3.8 | 15.2 | 9.9 | +67.3% |
| 2018 | -6.3 | -6.2 | 4.1 | 5.7 | 4.1 | 4.4 | 0.4 | 10.6 | -2.7 | -7.1 | -3.6 | -4.6 | −3.0% |
| 2017 | -2.3 | 5.5 | -1.1 | 4.7 | 0.9 | -1.3 | -2.3 | 0.3 | -1.8 | 1.4 | 5.9 | 9.1 | +20.0% |
| 2016 | -12.4 | 7.3 | 3.9 | -1.5 | 2.0 | 11.7 | 2.4 | -2.6 | 5.8 | 6.7 | 0.2 | 10.6 | +36.5% |
| 2015 | 6.7 | 5.5 | 0.4 | -0.8 | 1.7 | -0.1 | -8.0 | -2.4 | -8.4 | -3.5 | 10.7 | 7.2 | +7.3% |
| 2014 | 3.0 | 11.4 | -7.3 | -8.2 | -0.7 | -2.0 | -0.2 | 7.3 | 0.4 | 0.9 | 2.7 | -0.8 | +5.0% |
| 2013 | 0.5 | 10.0 | -8.5 | 1.8 | -6.7 | 5.4 | 2.6 | 4.3 | 8.8 | 6.1 | 1.0 | -3.6 | +21.7% |
| 2012 | 16.0 | 0.8 | 13.4 | 1.9 | -3.3 | 0.5 | -6.4 | 2.4 | 11.3 | -5.8 | 7.6 | 15.1 | +63.2% |
| 2011 | 4.1 | -4.9 | 16.5 | 15.0 | -1.0 | 3.1 | -3.0 | -13.2 | 0.9 | 0.9 | 3.5 | 1.9 | +22.4% |
| 2010 | 1.0 | -0.8 | 12.1 | 12.1 | 0.7 | 1.8 | 13.9 | -0.3 | 9.8 | -8.9 | 8.0 | -0.9 | +57.0% |
| 2009 | -8.0 | -4.3 | -15.9 | 18.9 | 23.2 | -1.8 | 2.6 | 14.3 | 10.9 | -4.6 | 4.1 | 2.9 | +41.4% |
| 2008 | -7.3 | -5.2 | -7.0 | 3.9 | 4.4 | -1.2 | -2.1 | 0.6 | -5.0 | -14.8 | -19.2 | 19.0 | −32.8% |
| 2007 | -0.9 | 1.4 | 2.2 | 9.7 | -1.0 | -7.5 | -0.8 | 2.9 | 19.6 | -5.3 | -9.1 | -2.1 | +6.2% |
Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Europe, North America, and internationally. It operates through three business sectors: Controls, Seals, and Life Sciences. The Controls sector offers wire and cabling, interconnect, specialty fasteners, specialty adhesive and industrial automation solutions for various applications. The Seals sector supplies sealing and fluid power products, gaskets, hoses and fittings, pumps and valves, and solutions for aftermarket repairs, original equipment manufacturing, and maintenance, repair and overhaul projects. The Life Sciences sector supplies and services equipment; provides consumables and instrumentation for surgery, diagnosis of disease, and critical care support; and supplies diagnostic and scientific technologies, surgical instruments, medical devices, endoscopes, patient monitoring equipment, specialist hospital supplies, and clinical nutrition. It serves public and private hospitals, clinics and diagnostics laboratories. Diploma PLC was incorporated in 1999 and is based in London, the United Kingdom.
Buy / hold / sell counts
No recent headlines.